SMS Pharmaceuticals Ltd (SMSPHARMA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 517655, "name": "SMS Pharma.", "stock_name": "SMS Pharma.", "full_name": "SMS Pharmaceuticals Ltd", "name_url": "stocks-analysis/sms-pharma", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "374.85", "chg": -9.85, "chgp": "-2.56%", "dir": -1, "prev_price": "384.70", "mcapval": "3,578.00 Cr", "mcap": "Small Cap", "scripcode": 532815, "symbol": "SMSPHARMA", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE812G01025", "curr_date": "Mar 23", "curr_time": "", "bse_nse_vol": "2.85 lacs", "exc_status": "Active", "traded_date": "Mar 23, 2026", "traded_date_str": "2026 03 23", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sms-pharma-517655-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "SMS Pharmaceuticals Ltd Valuation Shifts Amid Strong Market Performance", "link": "https://www.marketsmojo.com/news/stocks-in-action/sms-pharmaceuticals-ltd-valuation-shifts-amid-strong-market-performance-3906176", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SMSPharmaceutic_valuationdot_3906176.png", "date": "2026-03-23 08:00:21", "description": "SMS Pharmaceuticals Ltd has witnessed a significant shift in its valuation parameters, moving from an expensive to a very expensive rating, driven by a surge in its price-to-earnings (P/E) and price-to-book value (P/BV) ratios. Despite this, the company’s stock has delivered exceptional returns over multiple time horizons, outperforming the broader Sensex by a wide margin." }, { "title": "SMS Pharmaceuticals Ltd Surges 7.32% to Day's High of Rs 388.95 — Outperforms Sector by 4.45 Percentage Points", "link": "https://www.marketsmojo.com/news/stocks-in-action/sms-pharmaceuticals-ltd-hits-intraday-high-with-732-surge-on-20-mar-2026-3906533", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SMSPharmaceutic_priceRelatedfactors_3906533.png", "date": "2026-03-20 13:30:53", "description": "The Sensex advanced 1.03% on 20 Mar 2026, yet SMS Pharmaceuticals Ltd outpaced the broader market with a 7.32% gain, touching an intraday high of Rs 388.95. This 4.45-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally rather than a market-wide lift." }, { "title": "SMS Pharmaceuticals Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/sms-pharmaceuticals-ltd-is-rated-hold-3898650", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SMSPharmaceutic_mojoScore_3898650.png", "date": "2026-03-18 10:10:03", "description": "SMS Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook." }, { "title": "SMS Pharmaceuticals Ltd: Valuation Shift Signals Price Attractiveness Amid Sector Dynamics", "link": "https://www.marketsmojo.com/news/stocks-in-action/sms-pharmaceuticals-ltd-valuation-shift-signals-price-attractiveness-amid-sector-dynamics-3892596", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SMSPharmaceutic_valuationdot_3892596.png", "date": "2026-03-16 08:00:37", "description": "SMS Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from a very expensive to an expensive rating, reflecting evolving investor perceptions amid robust stock performance and sector dynamics. This article analyses the recent changes in key valuation metrics such as price-to-earnings (P/E) and price-to-book value (P/BV) ratios, comparing them with historical averages and peer benchmarks to assess the stock’s price attractiveness." }, { "title": "SMS Pharmaceuticals Ltd Falls 2.21%: 4 Key Factors Driving This Week's Volatility", "link": "https://www.marketsmojo.com/news/stocks-in-action/sms-pharmaceuticals-ltd-falls-221-4-key-factors-driving-this-weeks-volatility-3891828", "imagepath": "", "date": "2026-03-14 17:21:50", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Mar 2:</strong> Significant gap down opening amid market concerns</p>\n <p><strong>Mar 4:</strong> Moderate recovery with 1.19% gain despite Sensex decline</p>\n <p><strong>Mar 5:</strong> Strong rebound with 1.99% rise alongside Sensex gains</p>\n <p><strong>Mar 6:</strong> Week closes at Rs.375.70, down 2.21% for the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.384.20</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.375..." }, { "title": "SMS Pharmaceuticals Ltd’s Volatile Week: -1.49% Amid New Highs and Sharp Declines", "link": "https://www.marketsmojo.com/news/stocks-in-action/sms-pharmaceuticals-ltds-volatile-week--149-amid-new-highs-and-sharp-declines-3891258", "imagepath": "", "date": "2026-03-14 14:09:23", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Mar 9:</strong> Valuation shifts signal improved price attractiveness</p>\n <p><strong>Mar 10:</strong> New 52-week high at Rs.408.5 and intraday peak of Rs.410</p>\n <p><strong>Mar 11:</strong> Fresh 52-week high of Rs.433.8 amid mixed market</p>\n <p><strong>Mar 13:</strong> Intraday low at Rs.374.45 amid sharp price pressure</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.382.20</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs..." }, { "title": "Why is SMS Pharmaceuticals Ltd falling/rising?", "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-sms-pharmaceuticals-ltd-fallingrising-3890360", "imagepath": "", "date": "2026-03-14 01:13:39", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>The stock has been on a downward trajectory for the past three consecutive days, cumulatively losing 12.09% in value. On the day in question, it touched an intraday low of ₹366.20, marking a 9.12% decline from previous levels. The trading session was characterised by a wide price range of ₹37.75, indicating significant intraday volatility. The weighted average price suggests that a larger volume of shares exchanged hands closer to the day’s low, signalling selling dominance during the session.</p>\n<p>Despite this short-term weakness, SMS Pharmaceuticals has outperformed the broader market over longer periods. Year-to-date, the stock has gained 19.10%, contrasting sharply with the Sensex’s decline of 12.50%. Over the past year, the comp..." }, { "title": "SMS Pharmaceuticals Ltd Hits Intraday Low Amid Price Pressure on 13 Mar 2026", "link": "https://www.marketsmojo.com/news/stocks-in-action/sms-pharmaceuticals-ltd-hits-intraday-low-amid-price-pressure-on-13-mar-2026-3888936", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SMSPharmaceutic_priceRelatedfactors_3888936.png", "date": "2026-03-13 11:45:59", "description": "Shares of SMS Pharmaceuticals Ltd declined sharply on 13 Mar 2026, hitting an intraday low of Rs 374.45 as the stock faced significant price pressure, underperforming its sector and broader market indices amid a cautious market environment." }, { "title": "SMS Pharmaceuticals Ltd Hits New 52-Week High at Rs.433.8", "link": "https://www.marketsmojo.com/news/stocks-in-action/sms-pharmaceuticals-ltd-hits-new-52-week-high-at-rs4338-3885041", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SMSPharmaceutic_priceRelatedfactors_3885041.png", "date": "2026-03-11 10:49:09", "description": "SMS Pharmaceuticals Ltd has reached a significant milestone by hitting a new 52-week high of Rs.433.8, marking a notable surge in its stock price amid a challenging broader market environment." } ], "total": 740, "sid": "517655", "stock_news_url": "https://www.marketsmojo.com/news/sms-pharmaceuticals-517655" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "20-Mar-2026", "details": "Copy of Newspaper Publication", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Monitoring Agency Report", "datetime": "10-Feb-2026", "details": "Monitoring Agency Report for 31st Dec 2025", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "09-Feb-2026", "details": "Newspaper Publication", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "SMS Pharmaceuticals Ltd has declared <strong>40%</strong> dividend, ex-date: 22 Sep 25", "dt": "2025-09-22", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "SMS Pharmaceuticals Ltd has announced <strong>1:10</strong> stock split, ex-date: 17 Dec 15", "dt": "2015-12-17", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

Mar 2: Significant gap down opening amid market concerns

Mar 4: Moderate recovery with 1.19% gain despite Sensex decline

Mar 5: Strong rebound with 1.99% rise alongside Sensex gains

Mar 6: Week closes at Rs.375.70, down 2.21% for the week

Read full news article

SMS Pharmaceuticals Ltd’s Volatile Week: -1.49% Amid New Highs and Sharp Declines

2026-03-14 14:09:23

Key Events This Week

Mar 9: Valuation shifts signal improved price attractiveness

Mar 10: New 52-week high at Rs.408.5 and intraday peak of Rs.410

Mar 11: Fresh 52-week high of Rs.433.8 amid mixed market

Mar 13: Intraday low at Rs.374.45 amid sharp price pressure

Read full news article

Why is SMS Pharmaceuticals Ltd falling/rising?

2026-03-14 01:13:39

Recent Price Movement and Market Context

The stock has been on a downward trajectory for the past three consecutive days, cumulatively losing 12.09% in value. On the day in question, it touched an intraday low of ₹366.20, marking a 9.12% decline from previous levels. The trading session was characterised by a wide price range of ₹37.75, indicating significant intraday volatility. The weighted average price suggests that a larger volume of shares exchanged hands closer to the day’s low, signalling selling dominance during the session.

Despite this short-term weakness, SMS Pharmaceuticals has outperformed the broader market over longer periods. Year-to-date, the stock has gained 19.10%, contrasting sharply with the Sensex’s decline of 12.50%. Over the past year, the comp...

Read full news article

SMS Pharmaceuticals Ltd Hits Intraday Low Amid Price Pressure on 13 Mar 2026

2026-03-13 11:45:59

Shares of SMS Pharmaceuticals Ltd declined sharply on 13 Mar 2026, hitting an intraday low of Rs 374.45 as the stock faced significant price pressure, underperforming its sector and broader market indices amid a cautious market environment.

Read full news article

SMS Pharmaceuticals Ltd Hits New 52-Week High at Rs.433.8

2026-03-11 10:49:09

SMS Pharmaceuticals Ltd has reached a significant milestone by hitting a new 52-week high of Rs.433.8, marking a notable surge in its stock price amid a challenging broader market environment.

Read full news article

View All News